Home Newsfeeds Piper Sandler Maintains Neutral on State Street, Lowers Price Target to $75

Piper Sandler Maintains Neutral on State Street, Lowers Price Target to $75

Piper Sandler analyst Jeffery Harte maintains State Street (NYSE:STT) with a Neutral and lowers the price target from $78 to $75.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Piper Sandler analyst Jeffery Harte maintains State Street (NYSE:STT) with a Neutral and lowers the price target from $78 to $75.

General
News

Hilton Hotels Launches New Brand ‘Spark By Hilton’

By Shivani Kumaresan

January 11, 12:35 PM

Hilton Worldwide Holdings Inc (NYSE:HLT) has launched Spark by Hilton, the newest addition to its portfolio of brands. Spark by Hilton…

HLT

News

Immatics Biotechnologies Granted U.S. Patent #11,384,129 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

By Charles Gross

July 12, 6:45 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5399&f=G&l=50&d=PTXT&p=108&S1=20220712&OS=20220712&RS=20220712

IMMX

Herbalife Nutrition Q2 EPS $0.96 Down From $1.55 YoY, Sales $1.40B Down From $1.55B YoY

By Benzinga Newsdesk

August 2, 5:09 PM

Herbalife Nutrition (NYSE:HLF) reported quarterly earnings of $0.96 per share. This is a 38.06 percent decrease over earnings of $1.55 per share from the same period last year. The company reported $1.40 billion in

HLF

Bitcoin Drops But Remains Above $30,000; Compound Becomes Top Loser

By Lisa Levin

July 5, 10:00 AM

Bitcoin (CRYPTO: BTC) moved lower, but the cryptocurrency prices remained above the key $30,000 level on Wednesday. Ethereum (CRYPTO: ETH), also traded lower, but remained above the key $1,900 mark this morning.

$BSV

Piper Sandler Maintains Neutral on State Street, Lowers Price Target to $75

Related Posts

Hilton Hotels Launches New Brand ‘Spark By Hilton’

Immatics Biotechnologies Granted U.S. Patent #11,384,129 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Herbalife Nutrition Q2 EPS $0.96 Down From $1.55 YoY, Sales $1.40B Down From $1.55B YoY

Bitcoin Drops But Remains Above $30,000; Compound Becomes Top Loser